Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 12, 2005Journal of Clinical OncologyOpen Access

Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors

View Full Paper
Ask AI
Bookmark
Share

Authors

UHUte HegenbartDNDietger NiederwieserBSBrenda M. Sandmaier

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hegenbart et al. (2005) studied this question.

synapsesocial.com/papers/6a1b75cfdb618aee6aabecb2https://doi.org/10.1200/jco.2005.03.1765
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases1998 · 1,793 citations
  2. 2Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia1994 · 1,440 citations
  3. 3Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases2003 · 457 citations
  4. 4Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission2003 · 93 citations
  5. 5Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation2003 · 563 citations